Is Artivion (AORT) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
Artivion, Inc. (AORT)
Company Research
Source: Yahoo! Finance
Artivion (AORT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out. Artivion is one of 1067 companies in the Medical group. The Medical group currently sits at #4 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups. The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Artivion is currently sporting a Zacks Rank of #1 (Strong Buy). The Zacks Consensus Estimate for AORT's full-year earnings has moved 2500% higher within the past quarter. This signals that analyst sentiment is improving and the s
Show less
Read more
Impact Snapshot
Event Time:
AORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AORT alerts
High impacting Artivion, Inc. news events
Weekly update
A roundup of the hottest topics
AORT
News
- Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial ResultsPR Newswire
- Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year [Yahoo! Finance]Yahoo! Finance
- Is Artivion (AORT) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]Yahoo! Finance
- Artivion, Inc. (NYSE: AORT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $25.00 price target on the stock.MarketBeat
- ENSEMBLE ORTHOPEDICS ANNOUNCES 700TH IMPLANTATION OF ITS MINIMALLY-INVASIVE PYROCARBON INTERPOSITIONAL CMC [Yahoo! Finance]Yahoo! Finance
AORT
Earnings
- 2/15/24 - Beat
AORT
Sec Filings
- 4/1/24 - Form ARS
- 4/1/24 - Form DEFA14A
- 4/1/24 - Form DEF
- AORT's page on the SEC website